DEVICE: RHA® 4 Mepi (07640173233480)
Device Identifier (DI) Information
RHA® 4 Mepi
RHA® 4 Mepi - TSK - US
In Commercial Distribution
940033
Teoxane SA
RHA® 4 Mepi - TSK - US
In Commercial Distribution
940033
Teoxane SA
"One box of RHA® 4 Mepi contains two blisters and one instruction for use.
Each blister contains a 1,2mL prefilled syringe and two needles (27G 1/2).
Box Packaging (ID 07640173233411) is defined as unit of sales and identified with a serial number."
Device Characteristics
Labeling does not contain MRI Safety Information | |
No | |
No | |
Yes | |
Yes | |
No | |
Yes | |
Yes | |
No |
GMDN
[?]GMDN© Term Code, Names and Definitions (*Terms of Use): GMDN® is a registered trademark of The GMDN Agency. All rights reserved. Used under licence from The GMDN Agency Ltd.
GMDN Term Code | GMDN Term Name | GMDN Term Definition | GMDN Term Status [?] | Implantable? |
---|---|---|---|---|
47887 | Dermal tissue reconstructive material, microbe-derived, anaesthetic |
A sterile, bioabsorbable, bacteria-derived substance intended to be injected into the dermis/hypodermis of the skin, lip submucosa, and/or for supraperiosteal administration to add volume by serving as a space-occupying supplement to the intercellular matrix of connective tissue (dermal filler), typically to correct cutaneous contour deformities (e.g., wrinkles, folds, scars) associated with aging, injury, or degenerative lesions; it includes a local anaesthetic agent (e.g., lidocaine). It typically includes bacterial hyaluronic acid (HA) as the principal constituent and is typically preloaded in a disposable syringe; disposable needle(s)/cannula(e) dedicated to injection may be included.
|
Active | true |
FDA Product Code
[?]Product Code | Product Code Name |
---|---|
LMH | Implant, Dermal, For Aesthetic Use |
FDA Premarket Submission
FDA Premarket Submission Number [?] | Supplement Number [?] |
---|---|
Premarket Submission Number Not Available/Not Released |
Sterilization
Storage and Handling
[?]Storage and Handling |
---|
Special Storage Condition, Specify: Special Storage Condition, Specify: Store at room temperature (up to 25°C / 77°F). Do not expose to direct sunlight. Do not freeze. |
Clinically Relevant Size
[?]Size Type Text |
---|
No Device Sizes |
Device Record Status
5056cbfe-7a81-49d9-a028-8ac3f9a870da
October 28, 2024
1
October 18, 2024
October 28, 2024
1
October 18, 2024
Alternative and Additional Identifiers Additional Identifiers
Package DI
[?]Package DI Number | Quantity per Package | Contains DI Package | Package Discontinue Date | Package Status | Package Type |
---|---|---|---|---|---|
07640173233411 | 2 | 07640173233480 | In Commercial Distribution |
Secondary DI
[?]Issuing Agency [?] | Secondary DI Number |
---|---|
No Secondary DIs found |
Unit of Use DI
[?]
Unit of Use DI Number:
No Unit of Use DI Numbers Found
CLOSE
Direct Marking (DM)
[?]Production Identifier(s) in UDI
[?]Customer Contact
[?]
877-373-8669
Medical-us@teoxane.com
Medical-us@teoxane.com